Vascular Graft Market (2026 - 2035)

ID: MRFR/HC/5184-HCR 200 Pages Rahul Gotadki Last Updated: October 27, 2026
Vascular Graft Market Research Report By Type (Endovascular Grafts, Hemodialysis Grafts, Surgical Grafts, Biosynthetic Grafts), By Material (Polyester, Polytetrafluoroethylene, Biological Tissue, Composite Materials), By Application (Coronary Artery Bypass, Peripheral Vascular Disease, Aortic Aneurysm Repair, Dialysis), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) -Forecast to 2035
Vascular Graft Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)7.40%
2025 Market SizeUSD 2.02 Billion
2035 Market SizeUSD 4.11 Billion
Key Players
W. L. Gore & Associates
Getinge AB
Becton Dickinson
Terumo Corporation
Medtronic plc
B. Braun Melsungen
Opportunities
  • Tissue-Engineered Conduits for Dialysis Access
  • Emerging-Market Localization
  • Sensor-Enabled Post-Implant Monitoring
  1. 1 Market Overview |
    1. 1.1 Study Assumptions & Market Definition |
    2. 1.2 Scope of the Study |
    3. 1.3 Research Methodology
  2. 2 Market Summary & Key Report Takeaways |
    1. 2.1 Key Takeaways by Product Type |
    2. 2.2 Key Takeaways by Material & Application |
    3. 2.3 Key Takeaways by Geography
  3. 3 Market Size & Forecast (2021–2035) |
    1. 3.1 Historical Market Size (2021–2024) |
    2. 3.2 Base Year Estimate (2025) |
    3. 3.3 Forecast Market Size (2026–2035) |
    4. 3.4 Year-over-Year Growth Analysis
  4. 4 Market Dynamics — Drivers |
    1. 4.1 Disease Burden and Procedure Volume Growth |
    2. 4.2 Migration to Endovascular Repair |
    3. 4.3 Dialysis Access Expansion |
    4. 4.4 Coatings, Surface Engineering and Premium Mix
  5. 5 Market Dynamics — Restraints |
    1. 5.1 Patency and Graft Infection Limitations |
    2. 5.2 EU MDR Recertification Burden |
    3. 5.3 Procurement and Pricing Pressure
  6. 6 Market Opportunity Analysis |
    1. 6.1 Tissue-Engineered Conduits for Dialysis Access |
    2. 6.2 Emerging-Market Localization |
    3. 6.3 Sensor-Enabled Post-Implant Monitoring |
    4. 6.4 Pediatric and Congenital Reconstruction |
    5. 6.5 Ambulatory Care Migration |
    6. 6.6 Industry Value Chain Analysis |
    7. 6.7 Porter's Five Forces Analysis
  7. 7 Regional Analysis |
    1. 7.1 North America | |
      1. 7.1.1 US | |
      2. 7.1.2 Canada | |
      3. 7.1.3 Mexico |
    2. 7.2 Europe | |
      1. 7.2.1 Germany | |
      2. 7.2.2 UK | |
      3. 7.2.3 France | |
      4. 7.2.4 Italy | |
      5. 7.2.5 Spain | |
      6. 7.2.6 Nordic Countries | |
      7. 7.2.7 Russia | |
      8. 7.2.8 Rest of Europe |
    3. 7.3 Asia-Pacific | |
      1. 7.3.1 China | |
      2. 7.3.2 India | |
      3. 7.3.3 Japan | |
      4. 7.3.4 South Korea | |
      5. 7.3.5 ASEAN | |
      6. 7.3.6 Rest of Asia-Pacific |
    4. 7.4 South America | |
      1. 7.4.1 Brazil | |
      2. 7.4.2 Argentina | |
      3. 7.4.3 Rest of South America |
    5. 7.5 Middle East & Africa | |
      1. 7.5.1 Saudi Arabia | |
      2. 7.5.2 UAE | |
      3. 7.5.3 South Africa | |
      4. 7.5.4 Egypt | |
      5. 7.5.5 Rest of Middle East & Africa
  8. 8 Future Outlook (2026–2035) |
    1. 8.1 Algorithmic Patient Selection |
    2. 8.2 Point-of-Care Manufacturing |
    3. 8.3 Outcome-Linked Commercial Models |
    4. 8.4 Supply Chain and Sustainability Pressure
  9. 9 Segmentation Analysis |
    1. 9.1 By Product Type | |
      1. 9.1.1 Endovascular Stent Grafts | |
      2. 9.1.2 Peripheral Vascular Grafts | |
      3. 9.1.3 Hemodialysis Access Grafts | |
      4. 9.1.4 3D-Printed Bioresorbable Grafts | |
      5. 9.1.5 Other Graft Types |
    2. 9.2 By Material | |
      1. 9.2.1 ePTFE | |
      2. 9.2.2 Polyester (Dacron) | |
      3. 9.2.3 Biosynthetic | |
      4. 9.2.4 Polyurethane | |
      5. 9.2.5 Biological Tissue-Derived |
    3. 9.3 By Application | |
      1. 9.3.1 Aortic & Peripheral Aneurysm Repair | |
      2. 9.3.2 Peripheral Vascular Disease | |
      3. 9.3.3 Hemodialysis Access | |
      4. 9.3.4 Coronary Artery Disease | |
      5. 9.3.5 Other Applications |
    4. 9.4 By End User | |
      1. 9.4.1 Hospitals | |
      2. 9.4.2 Ambulatory Surgical Centers | |
      3. 9.4.3 Specialty Cardiovascular Centers | |
      4. 9.4.4 Other End Users
  10. 10 Competitive Landscape |
    1. 10.1 Market Concentration Analysis |
    2. 10.2 Competitive Benchmarking Matrix |
    3. 10.3 Company Profiles | |
      1. 10.3.1 W. L. Gore & Associates | |
      2. 10.3.2 Getinge AB (Vascutek) | |
      3. 10.3.3 Becton Dickinson (Bard Peripheral Vascular) | |
      4. 10.3.4 Terumo Corporation | |
      5. 10.3.5 Medtronic plc | |
      6. 10.3.6 B. Braun Melsungen | |
      7. 10.3.7 Cook Medical | |
      8. 10.3.8 LeMaitre Vascular | |
      9. 10.3.9 Artivion Inc. | |
      10. 10.3.10 Endologix LLC | |
      11. 10.3.11 Humacyte Inc.
  11. 11 Recent News & Developments
  12. 12 Report Scope & Methodology
  13. 13 Detailed Sources & Citations
  14. 14 Frequently Asked Questions
  15. 15 LIST OF TABLES |
  16. TABLE 1 Global Vascular Graft Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
  17. TABLE 2 Global Vascular Graft Market — Year-over-Year Growth Analysis, 2021–2035 |
  18. TABLE 3 Driver Impact Analysis — Estimated Contribution to CAGR, 2026–2035 |
  19. TABLE 4 Restraint Impact Analysis — Estimated Drag on CAGR, 2026–2035 |
  20. TABLE 5 Global Vascular Graft Market Size, by Product Type, 2021–2035 (USD Billion) |
  21. TABLE 6 Global Vascular Graft Market Size, by Material, 2021–2035 (USD Billion) |
  22. TABLE 7 Global Vascular Graft Market Size, by Application, 2021–2035 (USD Billion) |
  23. TABLE 8 Global Vascular Graft Market Size, by End User, 2021–2035 (USD Billion) |
  24. TABLE 9 Global Vascular Graft Market Size, by Region, 2021–2035 (USD Billion) |
  25. TABLE 10 North America Vascular Graft Market Size, by Country, 2021–2035 (USD Billion) |
  26. TABLE 11 Europe Vascular Graft Market Size, by Country, 2021–2035 (USD Billion) |
  27. TABLE 12 Asia-Pacific Vascular Graft Market Size, by Country, 2021–2035 (USD Billion) |
  28. TABLE 13 South America Vascular Graft Market Size, by Country, 2021–2035 (USD Billion) |
  29. TABLE 14 Middle East & Africa Vascular Graft Market Size, by Country, 2021–2035 (USD Billion) |
  30. TABLE 15 North America Market Size, by Product Type, 2021–2035 (USD Billion) |
  31. TABLE 16 North America Market Size, by Material, 2021–2035 (USD Billion) |
  32. TABLE 17 North America Market Size, by Application, 2021–2035 (USD Billion) |
  33. TABLE 18 Europe Market Size, by Product Type, 2021–2035 (USD Billion) |
  34. TABLE 19 Europe Market Size, by Material, 2021–2035 (USD Billion) |
  35. TABLE 20 Europe Market Size, by Application, 2021–2035 (USD Billion) |
  36. TABLE 21 Asia-Pacific Market Size, by Product Type, 2021–2035 (USD Billion) |
  37. TABLE 22 Asia-Pacific Market Size, by Material, 2021–2035 (USD Billion) |
  38. TABLE 23 Asia-Pacific Market Size, by Application, 2021–2035 (USD Billion) |
  39. TABLE 24 South America Market Size, by Product Type, 2021–2035 (USD Billion) |
  40. TABLE 25 South America Market Size, by Application, 2021–2035 (USD Billion) |
  41. TABLE 26 Middle East & Africa Market Size, by Product Type, 2021–2035 (USD Billion) |
  42. TABLE 27 Middle East & Africa Market Size, by Application, 2021–2035 (USD Billion) |
  43. TABLE 28 US Market Size, by Product Type and End User, 2021–2035 (USD Billion) |
  44. TABLE 29 Germany Market Size, by Product Type and Material, 2021–2035 (USD Billion) |
  45. TABLE 30 China Market Size, by Product Type and Application, 2021–2035 (USD Billion) |
  46. TABLE 31 India Market Size, by Application and End User, 2021–2035 (USD Billion) |
  47. TABLE 32 Japan Market Size, by Material and Application, 2021–2035 (USD Billion) |
  48. TABLE 33 Competitive Benchmarking Matrix — Key Players, 2026 |
  49. TABLE 34 Company Profiles — Offerings and Strategic Positioning |
  50. TABLE 35 Recent Developments & Strategic Announcements, 2023–2025 |
  51. TABLE 36 Report Scope & Methodology Summary |
  52. TABLE 37 Detailed Sources and Citations Index
  53. 16 LIST OF FIGURES |
  54. FIGURE 1 Market Dynamics — Drivers, Restraints and Opportunities Snapshot |
  55. FIGURE 2 Industry Value Chain Analysis — Raw Polymer to Implant |
  56. FIGURE 3 Porter's Five Forces Assessment |
  57. FIGURE 4 Global Market Size Trend Line, 2021–2035 (USD Billion) |
  58. FIGURE 5 Year-over-Year Growth Curve, 2022–2035 (%) |
  59. FIGURE 6 Revenue Share by Product Type, 2025 vs 2035 (%) |
  60. FIGURE 7 Revenue Share by Material, 2025 (%) |
  61. FIGURE 8 Revenue Share by Application, 2025 (%) |
  62. FIGURE 9 Revenue Share by End User, 2025 (%) |
  63. FIGURE 10 Regional Revenue Share Distribution, 2025 (%) |
  64. FIGURE 11 Regional CAGR Comparison, 2026–2035 (%) |
  65. FIGURE 12 Country-Level Growth Heat Map, 2026–2035 |
  66. FIGURE 13 Competitive Landscape — Estimated Revenue Share Bands, 2026 |
  67. FIGURE 14 Strategic Positioning Matrix — Innovation vs Scale |
  68. FIGURE 15 Technology Adoption S-Curve — Bioresorbable and Tissue-Engineered Conduits

Segmentation Quick Reference

DimensionSub-SegmentsDominant SegmentFastest Growing Segment
By Product TypeEndovascular Stent Grafts; Peripheral Vascular Grafts; Hemodialysis Access Grafts; 3D-Printed Bioresorbable Grafts; Other Graft TypesEndovascular Stent Grafts3D-Printed Bioresorbable Grafts
By MaterialePTFE; Polyester (Dacron); Biosynthetic; Polyurethane; Biological Tissue-DerivedePTFEBiosynthetic
By ApplicationAortic & Peripheral Aneurysm Repair; Peripheral Vascular Disease; Hemodialysis Access; Coronary Artery Disease; Other ApplicationsAortic & Peripheral Aneurysm RepairHemodialysis Access
By End UserHospitals; Ambulatory Surgical Centers; Specialty Cardiovascular Centers; Other End UsersHospitalsAmbulatory Surgical Centers
By RegionNorth America; Europe; Asia-Pacific; South America; Middle East & AfricaNorth AmericaAsia-Pacific

 

Market Segmentation Overview

By Product Type

Sub-SegmentKey Trend
Endovascular Stent GraftsOutpatient migration expands eligible procedure settings
Peripheral Vascular GraftsDiabetic limb salvage sustains steady replacement demand
Hemodialysis Access GraftsEarly-cannulation designs reduce catheter dependence
3D-Printed Bioresorbable GraftsPatient-specific geometry moves from research to pilot clinical use
Other Graft TypesPatch and carotid applications benefit from biologic alternatives

 

Product strategy is bifurcating. Volume leaders defend endovascular franchises through delivery-system integration and consignment inventory, while challengers concentrate capital on resorbable and bioengineered constructs that promise a structurally different long-term risk profile.

By Material

Sub-SegmentKey Trend
ePTFEHeparin bonding and antimicrobial impregnation lift average selling prices
Polyester (Dacron)Gelatin and collagen sealing remain standard in aortic reconstruction
BiosyntheticHybrid scaffolds attract clinical interest for host cell integration
PolyurethaneCompliance matching supports early-access dialysis use
Biological Tissue-DerivedPreferred where infection risk rules out synthetic conduits

 

Material innovation now competes on biology rather than mechanics. Suppliers investing in surface chemistry and controlled degradation profiles are capturing premium tiers, while uncoated commodity lines face the sharpest tender-driven price erosion.

By Application

Sub-SegmentKey Trend
Aortic & Peripheral Aneurysm RepairNational screening programs create predictable elective volume
Peripheral Vascular DiseaseDiabetes prevalence drives infrainguinal intervention growth
Hemodialysis AccessKidney failure incidence outpaces fistula creation capacity
Coronary Artery DiseaseSelective prosthetic use where autologous conduits are unavailable
Other ApplicationsTrauma and oncologic reconstruction open specialty demand

 

Application economics differ sharply. Aneurysm repair carries the highest per-procedure device value, whereas dialysis access delivers repeat purchases across a patient's treatment lifetime, making it the more attractive annuity for suppliers.

By End User

Sub-SegmentKey Trend
HospitalsRetain complex open and hybrid aortic caseloads
Ambulatory Surgical CentersReimbursement parity accelerates procedure migration
Specialty Cardiovascular CentersConcentrated expertise supports premium device adoption
Other End UsersDialysis clinics expand access-related procurement

 

Buying authority is dispersing away from centralized hospital supply chains. Vendors that build ambulatory-specific commercial models, including smaller consignment sets and simplified sizing matrices, will hold an advantage as outpatient share climbs through 2035.

 

 

 

 

 

 

 

 

 

 

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.